Derek Underwood

Derek Underwood is a seasoned professional with extensive experience in private equity and biotechnology. Currently serving as Principal at Cimbal Capital Group since May 2024, Derek focuses on value investing in technology products. Additionally, Derek holds advisory roles at ImmuneAGE Bio, Mitrix.bio, Tau Ventures, and Q Bio, contributing expertise in immune rejuvenation and biofluid metrics. As an investor, Derek has actively participated in companies like Endiatx and SoundMind. Previous roles include Chief Executive Officer and Chief Operating Officer at SensOmics Inc, and Global Product & Marketing Manager at INVISTA, where significant revenue growth and strategic initiatives were achieved. Derek holds an MBA in Finance and Entrepreneurship, as well as a BS in Chemical Engineering and Biomedical Engineering, both from Carnegie Mellon University.